CA

Carnegie Asset Management

Europe, Hovedstaden, Denmark, Copenhagen

Description

Carnegie Asset Management is a focused and independent asset manager. Their objective is to deliver consistent, long term asset growth for

Investor Profile

Carnegie Asset Management has backed more than 6 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 17% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C, Series B, Series Unknown rounds (top funding stages).
  • Majority of deals are located in Switzerland, Canada, United States.
  • Strong thematic focus on Biotechnology, Pharmaceutical, Health Care.

Stage Focus

  • Series C (50%)
  • Series B (33%)
  • Series Unknown (17%)

Country Focus

  • Switzerland (33%)
  • Canada (33%)
  • United States (33%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Health Care
  • Genetics
  • Life Science
  • Medical Device
  • Health Diagnostics
  • Business Development
  • Information Technology
  • Software
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Carnegie Asset Management frequently co-invest with?

Gimv
Europe, Antwerpen, Belgium, Antwerpen
Co-Investments: 2
HBM Healthcare Investments
Europe, Zug, Switzerland, Zug
Co-Investments: 2
Varuma
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1
Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1
3i Group
Europe, England, United Kingdom, London
Co-Investments: 2
NGN Capital
North America, New York, United States, New York
Co-Investments: 2
MF
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 2
Dow
North America, Michigan, United States, Midland
Co-Investments: 2
HI
Europe, Baden-Wurttemberg, Germany, Heidelberg
Co-Investments: 1
Oxford Bioscience Partners
North America, Massachusetts, United States, Boston
Co-Investments: 1

What are some of recent deals done by Carnegie Asset Management?

Santhera Pharmaceuticals

Liestal, Basel-Landschaft, Switzerland

Santhera Pharmaceuticals develops and markets pharmaceutical products for the treatment of mitochondrial and neuromuscular diseases.

BiotechnologyHealth CarePharmaceutical
Series COct 5, 2006
Amount Raised: $19,041,816
Genizon BioSciences

Montreal, Quebec, Canada

Genizon Biosciences discovers genes and biomarkers in common diseases using genome-wide association studies.

BiotechnologyGeneticsLife ScienceMedical Device
Series UnknownMar 29, 2006
Amount Raised: $12,000,000
Santhera Pharmaceuticals

Liestal, Basel-Landschaft, Switzerland

Santhera Pharmaceuticals develops and markets pharmaceutical products for the treatment of mitochondrial and neuromuscular diseases.

BiotechnologyHealth CarePharmaceutical
Series BDec 20, 2005
Amount Raised: $18,997,524
Genizon BioSciences

Montreal, Quebec, Canada

Genizon Biosciences discovers genes and biomarkers in common diseases using genome-wide association studies.

BiotechnologyGeneticsLife ScienceMedical Device
Series BDec 13, 2004
Amount Raised: $9,043,138
Agensys

Santa Monica, California, United States

Agensys offers products to treat various tumors as well as prostate, pancreatic and bladder cancers.

BiotechnologyHealth DiagnosticsPharmaceutical
Series CMar 4, 2002
Amount Raised: $42,800,000
ZoomON

San Jose, California, United States

ZoomON, a provider of flexible vector graphics solutions for business-to-business applications in Web and wireless environments.

Business DevelopmentInformation TechnologySoftwareWireless
Series CJun 21, 2000
Amount Raised: $8,000,000

Find More Investors Like Carnegie Asset Management

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Carnegie Asset Management | Pipeseed